Results 211 to 220 of about 127,576 (299)

Pediatric Huntington Disease Brains Have Distinct Morphologic and Metabolic Traits: the RAREST-JHD Study. [PDF]

Mov Disord Clin Pract
Caligiuri ME, Tinelli E, Vizza P, Giancaterino G, Cicone F, Cascini GL, Sabatini U, Squitieri F.   +7 more
europepmc   +1 more source

Epidemiology of progressive intellectual and neurological deterioration in UK children

Developmental Medicine &Child Neurology, Volume 68, Issue 3, Page 418-428, March 2026.
This study of PIND in UK children was carried out via the British Paediatric Surveillance Unit from 1997 to 2024. It identified six cases of vCJD. 2367 children had other diagnoses explain their deterioration. There were 259 other diseases in the diagnosed group.
Christopher M. Verity, Polly J. Maunder, Anne Marie Winstone, Suvankar Pal   +3 more
wiley   +1 more source

Dissemination of VMAT-2 Inhibitors: A New Class Drug for Tardive Dyskinesia and Huntington Disease. [PDF]

Neurol Clin Pract
Ma E, Krening E, Bruno MK.
europepmc   +1 more source

Changes in Italian Nurses' Genetic Knowledge and Perceptions Over a Decade

Nursing &Health Sciences, Volume 28, Issue 1, March 2026.
ABSTRACT Genetic knowledge is increasingly important in nursing, yet often seen as of limited relevance. This study examines Italian nurses' genetic knowledge and perceived relevance, comparing current findings with data from a 2011 survey. A cross‐sectional survey was carried out using a self‐administered questionnaire. A total of 504 nurses (95.1% of
Lea Godino, Camilla Elena Magi, Mattia Ricco, Daniela Turchetti   +3 more
wiley   +1 more source

Postmortem neuropathology in early Huntington disease. [PDF]

J Neuropathol Exp Neurol
Hedreen JC, Berretta S, White Iii CL.
europepmc   +1 more source

Mild Short‐Term Caloric Restriction Induces Coordinated Changes That Promote Lipid Deposition While Maintaining Thermogenesis Capacity in Interscapular Brown Adipose Tissue of Male Rats

The FASEB Journal, Volume 40, Issue 3, 15 February 2026.
Rats under mild caloric restriction (85% vs. ad libitum) for 2 weeks show metabolic and structural adaptations in iBAT. Caloric restriction increases glycolysis and triglyceride deposition in the tissue, leading to larger lipid droplets. It also reduces mitochondrial iBAT content, while maintaining iBAT thermogenic potential thanks to an increased ...
Giuliana Panico, Vincenzo Migliaccio, Gabriella Pinto, Anna Iliano, Gianluca Fasciolo, Martina Coletta, Paola Venditti, Maria Moreno, Angela Amoresano, Pieter de Lange, Lillà Lionetti, Assunta Lombardi   +11 more
wiley   +1 more source

Huntington Disease Health Related Quality of Life, Function and Well Being: The Patient's Perspective. [PDF]

Neurol Ther
Pérez-Pérez J, García-López S, Valle TF, Painous C, Querol-Pascual MR, Ruiz PJG, Diago EB, Cubo Delgado E, Pastor BV, Villaplana MCP, Santana IM, Blázquez Estrada M, Garride MC, Mir P, Álvarez C, Maurino J, de Prado A, López-Sendón JL.   +17 more
europepmc   +1 more source

A2A Adenosine Receptor Agonists With Last‐Step Enzymatic 18F‐Labelling Potential (Fluorinase) for Positron Emission Tomography (PET)

European Journal of Organic Chemistry, Volume 29, Issue 5, 7 February 2026.
This study exploits the comparable binding tolerances between the fluorinase enzyme and the A2A adenosine receptor towards the development of novel C‐2 functionalised 5′‐fluorodeoxy‐adenosine (FDA)‐based agonists with enzymatic 18F‐labelling capability for positron emission tomography (PET).
Nicolas Charalambous, Carina Schleidt, Rongfang Liu, Laura H. Heitman, Sergio Dall’Angelo, David O’Hagan, Phillip T. Lowe   +6 more
wiley   +1 more source

Atypical Presentations of Huntington Disease-like 2 in South African Individuals. [PDF]

Mov Disord Clin Pract
Narotam-Jeena H, Guttman M, van Hillegondsberg L, van Coller R, Krause A, Carr J.   +5 more
europepmc   +1 more source

Personalized Models of Biological Barriers and Their Diseases: Recent Progress with Organs‐On‐Chips

Advanced Biology, Volume 10, Issue 2, February 2026.
Buck and Bugter et al. explore the architectural diversity and physiological functions of human barrier systems and reveal how organ‐on‐chip platforms, particularly those integrating patient‐derived cells, are advancing barrier disease modeling. They highlight how emerging biological and technological advances can be used to bridge the gap between ...
Franziska Buck, Jeroen Bugter, Gizem Yorukoglu, Mina Kazemzadeh Dastjerd, Thomas E. Winkler   +4 more
wiley   +1 more source